Download PDF
Horm Metab Res 2006; 38(8): 546-548
DOI: 10.1055/s-2006-949529
Short Communication

© Georg Thieme Verlag KG Stuttgart · New York

Pigment Epithelium-derived Factor (PEDF) Blocks Angiotensin II-induced T Cell Adhesion to Endothelial Cells by Suppressing Intercellular Adhesion Molecule-1

S. -I. Yamagishi 1 , S. Kikuchi 2 , K. Nakamura 1 , T. Matsui 1 , T. Makino 3 , O. Norisugi 3 , T. Shimizu 3 , H. Inoue 4 , T. Imaizumi 1
  • 1Department of Internal Medicine III, Kurume University School of Medicine, Kurume, Japan
  • 2Department of Neurology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
  • 3Department of Dermatology, Faculty of Medicine, University of Toyama, Toyama, Japan
  • 4Radioisotope Institute for Basic and Clinical Medicine, Kurume University School of Medicine, Kurume, Japan
Further Information

Publication History

Received 8 December 2005

Accepted after revision 1 March 2006

Publication Date:
29 August 2006 (online)

Also available at
    Permissions and Reprints

Introduction

Pigment epithelium-derived factor (PEDF) was first isolated from the conditioned media of human retinal pigment epithelial cells with neuronal differentiating activity [1]. Recently, PEDF has been shown to be the most potent inhibitor of angiogenesis in the mammalian eye. PEDF inhibited retinal endothelial cell (EC) growth and migration and suppressed ischemia-induced retinal neovascularization [1], thus suggesting that PEDF could protect against the development and progression of proliferative diabetic retinopathy. However, the protective role for PEDF in early diabetic retinopathy is not fully understood.

Leukocyte adhesion to the capillary endothelium (leukostasis) is a critical event in early diabetic retinopathy, whose process is mainly mediated by intercellular adhesion molecule-1 (ICAM-1) expression [2]. Since the renin-angiotensin system is also postulated to participate in early phase of diabetic retinopathy [3] [4], we investigated whether PEDF could inhibit the angiotensin II (Ang II)-induced ICAM-1 expression in human microvascular ECs in vitro. We also investigated subsequent leukocyte adhesion to human microvascular ECs in vitro.

References

  • 1 Tombran-Tink J, Barnstable CJ. Nat Rev Neurosci. 2003;  4 628-636
    CrossrefPubMed
  • 2 Miyamoto K, Khosrof S, Bursell SE, Rohan R, Murata T, Clermont AC, Aiello LP, Ogura Y, Adamis AP. Proc Natl Acad Sci USA. 1999;  96 10836-10841
    CrossrefPubMed
  • 3 Nakamura H, Inoue T, Arakawa N, Shimizu Y, Yoshigae Y, Fujimori I, Shimakawa E, Toyoshi T, Yokoyama T. Eur J Pharmacol. 2005;  512 239-246
    CrossrefPubMed
  • 4 Nagisa Y, Shintani A, Nakagawa S. Diabetologia. 2001;  44 883-888
    CrossrefPubMed
  • 5 Yamagishi S, Inagaki Y, Nakamura K, Abe R, Shimizu T, Yoshimura A, Imaizumi T. J Mol Cell Cardiol. 2004;  3 497-506
    PubMed
  • 6 Staunton DE, Marlin SD, Stratowa C, Dustin ML, Springer TA. Cell. 1988;  52 925-933
    CrossrefPubMed
  • 7 Yamagishi S, Takeuchi M. Drugs Exp Clin Res. 2004;  30 163-168
    PubMed
  • 8 Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, Janicki H, Schraermeyer U, Kociok N, Fauser S, Kirchhof B, Kern TS, Adamis AP. FASEBJ. 2004;  18 1450-1452
    PubMed
  • 9 van Reyk DM, Gillies MC, Davies MJ. Redox Rep. 2003;  8 187-192
    CrossrefPubMed
  • 10 Mamputu JC, Renier G. J Leukoc Biol. 2004;  75 1062-1069
    CrossrefPubMed

Correspondence

Dr. Sho-ichi Yamagishi

Department of Internal Medicine III·Kurume University School of Medicine

67 Asahi-machi·Kurume 830-0011·Japan

Phone: +81/942/31 75 80

Fax: +81/942/31 77 07

Email: shoichi@med.kurume-u.ac.jp

      >